Co-Authors
This is a "connection" page, showing publications co-authored by Nicola Sverzellati and Athol Wells.
Connection Strength
2.022
-
Chest radiography or computed tomography for COVID-19 pneumonia? Comparative study in a simulated triage setting. Eur Respir J. 2021 09; 58(3).
Score: 0.967
-
Sarcoidosis: is cryobiopsy not cool enough? - Authors' reply. Lancet Respir Med. 2018 09; 6(9):e45.
Score: 0.194
-
Pulmonary sarcoidosis. Lancet Respir Med. 2018 05; 6(5):389-402.
Score: 0.190
-
Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper. Lancet Respir Med. 2018 02; 6(2):138-153.
Score: 0.185
-
Effect of Emphysema Extent on Serial Lung Function in Patients with Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2017 11 01; 196(9):1162-1171.
Score: 0.185
-
The Role of Chest Imaging in Patient Management during the COVID-19 Pandemic: A Multinational Consensus Statement from the Fleischner Society. Radiology. 2020 07; 296(1):172-180.
Score: 0.055
-
The Role of Chest Imaging in Patient Management During the COVID-19 Pandemic: A Multinational Consensus Statement From the Fleischner Society. Chest. 2020 07; 158(1):106-116.
Score: 0.055
-
Computed Tomographic Biomarkers in Idiopathic Pulmonary Fibrosis. The Future of Quantitative Analysis. Am J Respir Crit Care Med. 2019 01 01; 199(1):12-21.
Score: 0.050
-
Variable radiological lung nodule evaluation leads to divergent management recommendations. Eur Respir J. 2018 12; 52(6).
Score: 0.050
-
Transbronchial Cryobiopsies for the Diagnosis of Diffuse Parenchymal Lung Diseases: Expert Statement from the Cryobiopsy Working Group on Safety and Utility and a Call for Standardization of the Procedure. Respiration. 2018; 95(3):188-200.
Score: 0.047
-
Transbronchial Lung Cryobiopsy in Diffuse Parenchymal Lung Disease: Comparison between Biopsy from 1 Segment and Biopsy from 2 Segments - Diagnostic Yield and Complications. Respiration. 2017; 93(4):285-292.
Score: 0.044